Sen. Bernie Sanders (I-Vt.) has announced that a vote will be held on June 18 on whether to subpoena a senior executive from Novo Nordisk to appear before the Senate Health, Education, Labor and Pensions (HELP) Committee.
The vote will consider a subpoena for Doug Langa, executive vice president of North America Operations for the multinational firm, to testify about the cost of drugs Ozempic and Wegovy in the United States.
